Skip to main content
. 2021 Jul 16;12:680298. doi: 10.3389/fpsyt.2021.680298

Table 1.

Demographic and assessment characteristics of pediatric ARFID patients (n = 26) admitted to a specialized pilot clinic.

Aversive Hx (n= 6) Sensory (n= 2) Low appetite, limited interest (n= 8) ARFID-Mixed (n= 10) ARFID total (n= 26)
Median (SD) Range(min–max) Median (SD) Range(min–max) Median (SD) Range(min–max) Median (SD) Range(min–max) Median (SD) Range (min–max)
Assessment
Age (years) 15.54 (2.26) 10.76–17.43 12.02 (1.09) 11.77–13.77 15.17 (2.66) 9.49–17.51 13.85 (1.99) 9.82–16.63 13.86 (2.30) 9.49–17.51
BMI (kg/m2) 16.03 (2.23) 11.78–18.66 15.82 (1.01) 14.43–16.40 14.86 (2.13) 11.71–17.62 14.48 (2.70) 12.63–20.55 15.07 (2.35) 11.71–20.55
zBMI −2.06 (1.03) −3.75–0.64 −0.99 (1.06) −2.62–0.63 −2.53 (0.97) −4.05–1.27 −2.57 (1.64) −3.79–1.11 −2.29 (1.26) −3.84–1.11
HR (bpm) 73.00 (17.10) 54–112 77.00 (23.76) 73–116 88.00 (25.56) 49–130 81.50 (18.63) 45–111 82.50 (21.29) 45–130
%TGW 79.50 (7.86) 72–97 84.00 (9.54) 83–100 86.00 (5.40) 75–91 86.00 (6.93) 79–100 84.00 (6.46) 74–100
LOI (months) 13.00 (6.28) 4–24 129.00 (31.23) 84–144 60.00 (65.10) 19–182 86.00 (68.68) 3–177 60.00 (62.83) 3–182
End of treatment
Length of treatment (days) 314.0 (190.18) 32–670 693.0 (41.01) 664–722 307.0 (297.62) 40–1,001 425.50 (205.04) 169–804 409.00 (223.64) 132–1001
Age (years) 16.29 (1.95) 12.59–18.30 14.67 (1.52) 13.59–15.74 15.68 (2.24) 12.23–18.04 15.03 (1.77) 11.73–17.10 15.35 (2.00) 11.73–18.30
BMI (kg/m2) 19.33 (1.13) 17.12–20.65 16.73 (1.01) 16.01–17.44 16.70 (2.21) 12.49–19.11 19.33 (2.49) 14.28–21.91 17.94 (2.25) 12.49–21.91
zBMI −0.69 (0.52) −0.96–0.57 −1.42 (0.90) −2.06–0.78 −1.40 (1.17) −4.30–1.03 −0.45 (1.16) −2.93–1.13 −0.89 (1.07) −3.61–1.13
%TGW 100.00 (7.39) 81–100 96.00 (5.66) 92–100 97.50 (6.14) 82–100 100.00 (0.00) 100–100 100.00 (4.39) 81–100

BMI, body mass index; zBMI, standardized body mass index by age and sex; HR, heart rate; %TGW, percent of treatment goal weight; LOI, length of illness prior to hospitalization.